SCHEMBL10099588

SCHEMBL10099588

CNCCC(=O)Nc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
HTT P42858 1/20 0.59
ALDH1A1 P00352 1/20 0.59
HPGD P15428 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
HDAC4 P56524 8/20 0.57
HDAC1 Q13547 8/20 0.57
HDAC7 Q8WUI4 8/20 0.57
HDAC11 Q96DB2 8/20 0.57
HDAC8 Q9BY41 8/20 0.57
HDAC6 Q9UBN7 8/20 0.57
HDAC9 Q9UKV0 8/20 0.57
HDAC5 Q9UQL6 8/20 0.57
HDAC3 O15379 7/20 0.57
HDAC2 Q92769 7/20 0.57
HDAC10 Q969S8 7/20 0.57
LTA4H P09960 2/20 0.56
CYP3A4 P08684 2/20 0.56
KDM4E B2RXH2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10099593 0.89 LTA4H (0.68) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL3342586 0.83 L3MBTL1 (0.80) MAPTL3MBTL1HTTALDH1A1HPGD
SCHEMBL9222067 0.81 SMN1; SMN2 (0.59) MAPTL3MBTL1HTTALDH1A1HPGD
SCHEMBL21322008 0.80 HDAC3 (0.64) MAPTHPGDSMN1; SMN2HDAC4HDAC1
SCHEMBL12210902 0.80 MAPT (0.66) MAPTHTTALDH1A1HPGDSMN1; SMN2
SCHEMBL10099561 0.80 HDAC4 (0.56) MAPTL3MBTL1HTTALDH1A1HPGD
SCHEMBL9888 0.80 ALDH1A1 (0.86) MAPTL3MBTL1HTTALDH1A1HPGD
SCHEMBL5969586 0.80 CA1 (0.59) MAPTL3MBTL1HTTALDH1A1HPGD
SCHEMBL517309 0.79 HDAC4 (0.81) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL6296181 0.79 HDAC4 (0.75) MAPTL3MBTL1HTTHDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247496-A1 2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS ARCUS BIOSCIENCES, INC. (US) 2020-12-10 WO disclosed
US-8093227-B2 Monosaccharide compounds and methods therefor ALCHEMIA PTY LTD (AU) 2012-01-10 US disclosed
US-20100184607-A1 MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR ALCHEMIA PTY LTD. (AU) 2010-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184607-A1 MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR SLC5A1, UGGT1, MRPL21 MAPT 4099/4885L3MBTL1 2971/4885HTT 4103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.